Posted on June 5, 2008 by crimsoncanary
Data to be presented at this weeks ADA meeting show Tranzyme’s Ghrelin Agonist TZP-101 to reduce gastric emptying in patients with diabetes and severe symptomatic gastroparesis.
Filed under: Uncategorized | Tagged: agonist, ghrelin, Tranzyme, TZP-101, TZP101 | Leave a Comment »
Posted on June 5, 2008 by crimsoncanary
EPIX Pharmaceuticals has achieved a key milestone in its collaboration with GlaxoSmithKline. EPIX has delivered a third GPCR candidate into lead optimization
Filed under: gpcr | Tagged: Epix, GlaxoSmithkline, gpcr, GSK, Research | Leave a Comment »